PDGFRB and neoplasm: Furthermore, patient outcomes were analyzed with respect to the integrin α11/PDGFRβ+ CAF subgroup, showing that an increase in stromal density of integrin α11/PDGFR was associated with higher tumor grade, metastasis, and patient mortality.